(Pharmamar) PharmaMar (MSE:PHM) has announced today a licensing agreement with Eczasibasi Group to commercialize the marine-derived anticancer drug Aplidin® (plitidepsin) in Turkey.
############
Story Source: Materials provided by Scienmag
PharmaMar and Eczasibasi sign a licensing agreement for Aplidin® in Turkey
Related Posts
Please login to join discussion
POPULAR NEWS
-
NYU Abu Dhabi researchers identify unique survival strategies adopted by fish in the world’s warmest waters
-
CHOP experts describe types of rashes associated with MIS-C
-
Scientists discover that a protein associated with neurodegenerative diseases is also linked to childhood brain cancer
-
Automatic design of metaheuristics: The future of optimization?